Patents Assigned to Dermal Devices, Inc.
  • Patent number: 9022932
    Abstract: A method and an apparatus for measuring glucose level in the body fluid of a subject, typically blood glucose level, by measuring impedance of a body tissue, with two pairs of electrodes, two electrodes for injecting current into a body tissue and two electrodes for detecting the ensuing voltage of the body tissue. The body tissue is typically a sub-dermal or sub-cutaneous tissue. The measured impedance of the body tissue is used to correlate with directly determined glucose levels to determine the glucose level from the measured impedance. It is thus possible to determine body fluid glucose levels in a reliable and reproducible manner.
    Type: Grant
    Filed: February 4, 2005
    Date of Patent: May 5, 2015
    Assignee: Dermal Devices, Inc.
    Inventors: Stig Ollmar, Peter Aberg, Ulrik Birgersson, Fredrik Neiderud